FDA Approves Two New Antibiotics to Treat Drug-Resistant Gonorrhea

Intracellular Neisseria gonorrhoeae bacteria with gram staining, viewed under a microscope.

Key Takeaways

  • The U.S. Food and Drug Administration approved two new antibiotics for gonorrhea for the first time in decades

  • One drug, zoliflodacin, is taken as a pill rather than as an injection

  • The approvals come as antibiotic resistance continues to rise worldwide

Originally published on healthday.com, part of the BLOX Digital Content Exchange.